Emulate Stock

emulatebio.comHealthcare / BioTech & PharmaFounded: 2014Funding to Date: $300.45MM

Emulate is a biotechnology company developing advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Emulate, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Emulate’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Emulate.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Geraldine Hamilton Ph.D
Chief Scientific Officer & President
Lewis Rowe
Chief Strategist
Daniel Levner Ph.D
Co-Founder & Chief Technology Officer
Harry Dhaliwal
Chief Financial Officer
David Coon
Chief Executive Officer
Donald Ingber Ph.D
Scientific Founder & Chair of the Scientific Advisory Board

Board Members

Eric Moessinger
Sharon Kedar
Aaron VanDevender Ph.D
Founders Fund
Frank Witney Ph.D
Donald Ingber Ph.D
Shlomo Melmed

Emulate stock FAQs

plusminus

Can you buy Emulate stock?

As Emulate is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Emulate, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Emulate stock?

To invest in a private company like Emulate through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Emulate stock?

Yes, you may be able to sell your Emulate stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Emulate stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Emulate stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Emulate a public company?

No, Emulate is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Emulate’s stock price?

Emulate is a privately held company and therefore does not have a public stock price. However, you may access Emulate’s private market stock price with Forge Data.
plusminus

What is Emulate’s stock ticker symbol?

Emulate does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Emulate, Inc., a leading provider of next-generation in vitro models, today announced that it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023.
Of the drugs that pass animal tests, more than 90% later fail in human clinical trials. But better technology could begin to replace the use of some animals—and make drug development cheaper and more effective.
For nearly a century, the drug trial process has remained the same. Researchers use animal testing before advancing drugs to human clinical trials. But this method is imperfect.
Emulate’s plan is to invest more heavily in R&D, and create specific organ-on-a-chip applications that they’ve homed in on through conversations with drug companies. So far, Emulate counts 21 major drug companies, including Genentech andJohnson & Johnson as customers.
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.